Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Early glibenclamide treatment in a clinical newborn with KCNJ11 gene mutation.

Diabetes care - 1 Oct 2007

Däublin Gerhard, Lorenz-Depiereux Bettina, Strom Tim M, Blankenstein Oliver, Raile Klemens

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Substitution
Share to Genetic Carrier Screening
Share to Glyburide
Share to Hypoglycemic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Infant

Share to Mutation

Share to Potassium Channels, Inwardly Rectifying

Share to Treatment Outcome

Source

Identifiers

PMID: 17901525
DOI: 10.2337/dc07-1318

Genes

KCNJ11

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Early glibenclamide treatment in a clinical newborn with KCNJ11 gene mutation.PMID 17901525Read ↗

KCNJ10 gene mutation in an 8-year-old boy with seizures.Semantic proximity Read ↗

Early Postnatal Use of Glibenclamide in Permanent Neonatal Diabetes Secondary to Antenatally Diagnosed KJCN11 Mutation.Semantic proximity Read ↗

Early transition to sulfonylurea therapy in infant with DEND syndrome due to F132L ABCC8 mutation.Semantic proximity Read ↗

De novo KCNMA1 mutations in children with early-onset paroxysmal dyskinesia and developmental delay.Semantic proximity Read ↗

Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11Semantic proximity Read ↗

Mild phenotype in a patient with developmental and epileptic encephalopathy carrying a novel de novo KCNB1 variant.Semantic proximity Read ↗

KCNJ11 in-frame 15-bp deletion leading to glibenclamide-responsive neonatal diabetes mellitus in a Chinese child.Semantic proximity Read ↗

Successful transition to sulfonylurea in neonatal diabetes, developmental delay, and seizures (DEND syndrome) due to R50P KCNJ11 mutation.Semantic proximity Read ↗

Sulfonylurea use during entire pregnancy in diabetes because of KCNJ11 mutation: a report of two cases.Semantic proximity Read ↗

Ketogenic diet as a successful early treatment modality for SCN2A mutationSemantic proximity Read ↗

Long-term efficacy of glibenclamide and sitagliptin therapy in adult patients with KCNJ11 permanent diabetes.Semantic proximity Read ↗

Use of the newborn screening card to define cause of death in a 12-year-old diagnosed with epilepsy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.